Skip to main content
PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · PMVP ISIN · US69353Y1038 US Manufacturing
Filings indexed 357 across all filing types
Latest filing 2023-05-19 Major Shareholding Noti…
Country US United States of America
Listing US PMVP

About PMV Pharmaceuticals, Inc.

https://www.pmvpharma.com/

PMV Pharmaceuticals, Inc. is a clinical-stage precision oncology company focused on the discovery and development of small molecule, tumor-agnostic therapies. The company's research centers on the p53 tumor suppressor protein, which is mutated in approximately half of all human cancers. PMV Pharmaceuticals develops first-in-class drug candidates, referred to as p53 regulators, designed to selectively target these mutations. The company's therapeutic approach aims to structurally correct the mutated p53 protein, thereby restoring its normal, wild-type tumor-suppressing function to treat various forms of cancer.

Recent filings

Filing Released Lang Actions
SC 13G
Major Shareholding Notification
2023-05-19 English
FORM 4 SUBMISSION
Director's Dealing
2023-05-15 English
FORM 4 SUBMISSION
Director's Dealing
2023-05-15 English
FORM 4 SUBMISSION
Director's Dealing
2023-05-15 English
FORM 4 SUBMISSION
Director's Dealing
2023-05-15 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-05-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.